According to the analysis, North America is expected to dominate the global alpha-amylase baking enzyme market, with the U.S. leading the regional growth. By 2032, the U.S. market is projected to reach a valuation of USD 162.4 million, growing at a CAGR of 3.4%. This growth is driven by new product launches, the presence of …